Hereditary Breast & Ovarian Cancer - BRCA Testing

Hereditary Breast & Ovarian Cancer - BRCA Testing

Rs.16,800.00 - Rs.68,000.00
Testing for BRCA1 & BRCA2 genes is used for the diagnosis of a hereditary form of breast & ovarian cancer. Presence of mutations in BRCA genes increases the lifetime risk of developing breast/ovarian cancer from 8% to 50-80%.

While full gene sequencing of BRCA1&2 genes will identify a majority of positive cases, it is highly recommended to also test for large deletions and duplications using a technique called MLPA.
Testing Options
Choose Quantity
+ Add to Cart
Product Details
- 5-10% of patients with breast and/or ovarian cancer have a hereditary form of the disease called Hereditary Breast & Ovarian Cancer (HBOC) syndrome.
- An individual carrying a mutation in BRCA1 or BRCA2 has an increased lifetime risk of developing breast/ovarian cancer of up to 50-85%. In the general population in India, the lifetime risk of women who will develop breast cancer is about 8%.
- By detecting cancer early and understanding your predisposition, you can have timely access to preventive measures and proactive treatment leading to much better outcomes.
- Somatic testing of BRCA1&2 can help in identifying cases that are more amenable to some specific drugs that target the BRCA pathway very effectively.
- If you are a person with breast cancer below the age of 50, ovarian cancer at any age, have multiple cancers or have a strong family history of cancers, you will benefit by speaking to our counsellors.
-Download this brochure for more information about BRCA testing from our partner laboratory, Centogene AG.
Added to cart
- There was an error adding to cart. Please try again.
Quantity updated
- An error occurred. Please try again later.
Deleted from cart
- Can't delete this product from the cart at the moment. Please try again later.